News & Insights
NuView Life Sciences Provides Corporate Update On NV-VPAC1 Theranostic for Breast Cancer 10.5.22
Advancements in Cancer Treatment -
Targeting VPAC1 Receptors for Imaging Glioblastoma
1.25.22
Research Article
Malignant glioblastoma (MG) is the most common primary tumor of the cerebral hemisphere [1]. Glioblastoma multiforme, among them, is highly malignant and present poor prognosis. Despite the advances in treatment of MG, the disease remains largely incurable [2, 3]. read more
Global Expansion -
NuView Life Sciences Creates Subsidiary for Latin American Market
11.7.21
Press Release
PARK CITY, UT NuView Life Sciences, Inc (“NuView”, the “company”), a clinical-stage oncology company focusing on innovative approaches to diagnose and treat cancers establishes NuView LATAM (“NV-LATAM”) in Mexico City.
read more
Sign up for important updates and announcements.
Sign up to receive instant updates
Contact Us
